UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study

Archives of neurology (Chicago), 2012-05, Vol.69 (5), p.594

2012

Link zum Volltext

Verfügbarkeit prüfen

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

Archives of neurology (Chicago), 2004-12, Vol.61 (12), p.1859

2004

Link zum Volltext

Verfügbarkeit prüfen

New presenilin 1 mutation with Alzheimer disease and Lewy bodies

Archives of neurology (Chicago), 2005-12, Vol.62 (12), p.1808

Rosenberg, Roger N

2005

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

Archives of neurology (Chicago), 2010-08, Vol.67 (8), p.949

2010

Link zum Volltext

Verfügbarkeit prüfen

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition

Archives of neurology (Chicago), 2012-05, Vol.69 (5), p.636

2012

Link zum Volltext

Verfügbarkeit prüfen

Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP

Archives of neurology (Chicago), 2010-08, Vol.67 (8), p.987

2010

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal change of biomarkers in cognitive decline

Archives of neurology (Chicago), 2011-10, Vol.68 (10), p.1257

2011

Link zum Volltext

Verfügbarkeit prüfen

Shapes of the trajectories of 5 major biomarkers of Alzheimer disease

Archives of neurology (Chicago), 2012-07, Vol.69 (7), p.856

2012

Link zum Volltext

Verfügbarkeit prüfen

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

Archives of neurology (Chicago), 2012-01, Vol.69 (1), p.96

2012

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

Archives of neurology (Chicago), 2009-05, Vol.66 (5), p.638

2009

Link zum Volltext

Verfügbarkeit prüfen

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

Archives of neurology (Chicago), 2003-01, Vol.60 (1), p.29

2003

Link zum Volltext

Verfügbarkeit prüfen

Role of family history for Alzheimer biomarker abnormalities in the adult children study

Archives of neurology (Chicago), 2011-10, Vol.68 (10), p.1313

2011

Link zum Volltext

Verfügbarkeit prüfen

Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype

Archives of neurology (Chicago), 2007-05, Vol.64 (5), p.738

2007

Link zum Volltext

Verfügbarkeit prüfen

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease

Archives of neurology (Chicago), 2000-01, Vol.57 (1), p.100

2000

Link zum Volltext

Verfügbarkeit prüfen

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid

Archives of neurology (Chicago), 2009-04, Vol.66 (4), p.448

2009

Link zum Volltext

Verfügbarkeit prüfen

Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment

Archives of neurology (Chicago), 2010-07, Vol.67 (7), p.867

2010

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

Archives of neurology (Chicago), 2009-03, Vol.66 (3), p.382

2009

Link zum Volltext

Verfügbarkeit prüfen

Age and apolipoprotein E4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition

Archives of neurology (Chicago), 2006-07, Vol.63 (7), p.936

2006

Link zum Volltext

Verfügbarkeit prüfen

Brain traffic: subcellular transport of the amyloid precursor protein

Archives of neurology (Chicago), 2009-04, Vol.66 (4), p.433

2009

Link zum Volltext

Verfügbarkeit prüfen

Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects

Archives of neurology (Chicago), 2007-11, Vol.64 (11), p.1672

2007

Link zum Volltext

Verfügbarkeit prüfen

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder

Archives of neurology (Chicago), 2012-01, Vol.69 (1), p.72

2012

Link zum Volltext

Verfügbarkeit prüfen

Plasma ß-amyloid and cognitive decline

Archives of neurology (Chicago), 2010-12, Vol.67 (12), p.1485

2010

Link zum Volltext

Verfügbarkeit prüfen

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

Archives of neurology (Chicago), 2009-03, Vol.66 (3), p.352

2009

Link zum Volltext

Verfügbarkeit prüfen

Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans

Archives of neurology (Chicago), 2007-04, Vol.64 (4), p.541

2007

Link zum Volltext

Verfügbarkeit prüfen

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease

Archives of neurology (Chicago), 1998-07, Vol.55 (7), p.1001

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Zeitschrift / SerieArchives Of Neurology

Suchergebnisse filtern

Filter anzeigen

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Humans
(26)
Male
(19)
Aged
(18)
Clinical Neurology
(18)
Female
(18)
Life Sciences & Biomedicine
(18)
Neurosciences & Neurology
(18)
Science & Technology
(18)
Neurology
(17)
Aged, 80 And Over
(16)
Alzheimer Disease - Genetics
(16)
Amyloid Beta-Peptides - Cerebrospinal Fluid
(15)
Peptide Fragments - Cerebrospinal Fluid
(15)
Middle Aged
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Alzheimer Disease - Cerebrospinal Fluid
(11)
Alzheimer's Disease
(10)
Adult
(9)
Apolipoprotein E4 - Genetics
(9)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the Framingham Heart Study

Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease

New presenilin 1 mutation with Alzheimer disease and Lewy bodies

Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition

Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP

Longitudinal change of biomarkers in cognitive decline

Shapes of the trajectories of 5 major biomarkers of Alzheimer disease

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type

Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism

Role of family history for Alzheimer biomarker abnormalities in the adult children study

Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease

Reduction of SorLA/LR11, a sorting protein limiting beta-amyloid production, in Alzheimer disease cerebrospinal fluid

Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment

Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

Age and apolipoprotein E4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition

Brain traffic: subcellular transport of the amyloid precursor protein

Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder

Plasma ß-amyloid and cognitive decline

PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia

Association of increased cortical soluble abeta42 levels with diffuse plaques after severe brain injury in humans

Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease

Aktive Filter

Suchergebnisse filtern